RECENT NEWS

'Vaccines As Tools To Combat Antimicrobial Resistance' is due to take place as an in-person meeting on 27–28 February 2023, at Edgbaston Park Hotel and Conference Centre in Birmingham, UK.

The Swedish medtech company Capitainer AB has announced that Professor Mathias Uhlén is investing in the company and joining the company’s advisory board. Mathias Uhlén is a world-leading scientist in biotechnology and proteomics and a successful serial entrepreneur.

SamanTree Medical has announced the publication of clinical data in prostate cancer, expanding the potential clinical utility of its proprietary medical imaging platform, the Histolog Scanner.

Health Education England’s Allied Health Professions Lead, Professor Beverley Harden, has been awarded an MBE in the New Year Honours list for services to healthcare.

ChromaDex, a global bioscience company dedicated to healthy ageing, announced promising new findings based on a previously published clinical trial of the company’s proprietary Niagen ingredient (patented nicotinamide riboside [NR]), which was supported by the ChromaDex External Research Program (CERP).

ViroStat has released its new catalogue of infectious disease antibodies and antigens. This latest release includes 790 antibodies for use in antigen detection assays such as lateral-flow rapid tests, ELISA, IFA and CLIA. Many recommended pairs are available. Infectious targets include viruses, bacteria, toxins, parasites and fungi.

Digital pathology and clinical AI firm Paige has published the results of a pivotal study demonstrating accuracy gains in pathologists’ diagnosis of prostate cancer when using Paige Prostate Detect, an FDA-authorised AI software that assists pathologists in the detection of foci that are suspicious for cancer during the review of scanned whole slide images (WSI) from prostate needle biopsies.

Inspirata and Fujifilm Corporation have signed an asset purchase agreement for Fujifilm to acquire Inspirata’s Dynamyx digital pathology technology, employees and customers, building off the proven success of the established partnership between the companies in UK and Europe.

EKF Diagnostics has launched a new version of its Lactate Scout analyser, designed specifically for use in veterinary settings. Lactate Scout Vet uses the same proven technology that was initially developed to provide elite sports coaches and athletes with a precise and easy-to-use handheld lactate test.

The latest edition of The Biomedical Science Industry Handbook is now available in print and digital format. It is a compendium of concise yet comprehensive information on the full range of products and services available from the IVD industry.

A new Community Diagnostic Centre (CDC) in Oldham - one of the country’s largest out-of-hospital diagnostic centres - is now open.

Sphere Fluidics, a company developing single-cell analysis systems underpinned by its patented picodroplet technology, has appointed Richard Hammond as Chief Technical Officer.

PhenoVista Biosciences a provider of both custom and off-the-shelf, imaging-based assay services based in San Diego, California, has announced a strategic investment by Fujifilm Corporation, Tokyo.

UK genomics company, RevoluGen Ltd has entered into a non-exclusive distribution agreement with BioEntist of Thailand for the distribution of its Fire Monkey High Molecular Weight (HMW)-DNA extraction product range.

Point-of-care diagnostics company LumiraDX has received $14.2 million in grants from the Bill & Melinda Gates Foundation for ongoing development of its point-of-care molecular tuberculosis (TB) testing system.

SEHTA and IVDeology are presenting a free-to-attend webinar to start-up companies who want to know more about quality management systems and how they impact an organisation.

The Government has announced over £175 million of funding to create the most advanced genomic healthcare system in the world, helping to save lives and improve health outcomes.

The December 2022 edition of Pathology in Practice has been published and is available to read online.

The Native Antigen Company (part of LGC Clinical Diagnostics) has announced the commercial release of its Sudan Ebolavirus Boniface 1976 Glycoprotein (SEBOV GP).

Students in the College of Health and Life Sciences at Aston University are to benefit from a major £4.8 million investment in new facilities funded by the Office for Students to further expand and develop the University’s suite of state-of-the-art healthcare simulation and laboratory facilities.